BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 33307459)

  • 1. Diagnostic performance between MR amide proton transfer (APT) and diffusion kurtosis imaging (DKI) in glioma grading and IDH mutation status prediction at 3 T.
    Xu Z; Ke C; Liu J; Xu S; Han L; Yang Y; Qian L; Liu X; Zheng H; Lv X; Wu Y
    Eur J Radiol; 2021 Jan; 134():109466. PubMed ID: 33307459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion-weighted MRI models.
    Guo H; Liu J; Hu J; Zhang H; Zhao W; Gao M; Zhang Y; Yang G; Cui Y
    J Magn Reson Imaging; 2022 Dec; 56(6):1834-1844. PubMed ID: 35488516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of the diffusion kurtosis imaging and diffusion tensor imaging in grading gliomas, predicting tumour cell proliferation and IDH-1 gene mutation status.
    Zhao J; Wang YL; Li XB; Hu MS; Li ZH; Song YK; Wang JY; Tian YS; Liu DW; Yan X; Jiang L; Yang ZY; Chu JP
    J Neurooncol; 2019 Jan; 141(1):195-203. PubMed ID: 30414095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimension amide proton transfer MRI of rectal adenocarcinoma: correlation with pathologic prognostic factors and comparison with diffusion kurtosis imaging.
    Chen W; Li L; Yan Z; Hu S; Feng J; Liu G; Liu B; Liu X
    Eur Radiol; 2021 May; 31(5):3286-3296. PubMed ID: 33125558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histogram analysis of diffusion kurtosis imaging derived maps may distinguish between low and high grade gliomas before surgery.
    Qi XX; Shi DF; Ren SX; Zhang SY; Li L; Li QC; Guan LM
    Eur Radiol; 2018 Apr; 28(4):1748-1755. PubMed ID: 29143940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.
    Jiang S; Zou T; Eberhart CG; Villalobos MAV; Heo HY; Zhang Y; Wang Y; Wang X; Yu H; Du Y; van Zijl PCM; Wen Z; Zhou J
    Magn Reson Med; 2017 Sep; 78(3):1100-1109. PubMed ID: 28714279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mean apparent propagator-MRI in evaluation of glioma grade, cellular proliferation, and IDH-1 gene mutation status.
    Sun Y; Su C; Deng K; Hu X; Xue Y; Jiang R
    Eur Radiol; 2022 Jun; 32(6):3744-3754. PubMed ID: 35076759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amide proton transfer-weighted imaging and derived radiomics in the classification of adult-type diffuse gliomas.
    Wu M; Jiang T; Guo M; Duan Y; Zhuo Z; Weng J; Xie C; Sun J; Li J; Cheng D; Liu X; Du J; Zhang X; Zhang Y; Liu Y
    Eur Radiol; 2024 May; 34(5):2986-2996. PubMed ID: 37855851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion kurtosis imaging in evaluating gliomas: different region of interest selection methods on time efficiency, measurement repeatability, and diagnostic ability.
    Chu JP; Song YK; Tian YS; Qiu HS; Huang XH; Wang YL; Huang YQ; Zhao J
    Eur Radiol; 2021 Feb; 31(2):729-739. PubMed ID: 32857204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the value of DKI and DTI in detecting isocitrate dehydrogenase genotype of astrocytomas.
    Tan Y; Zhang H; Wang X; Qin J; Wang L; Yang G; Yan H
    Clin Radiol; 2019 Apr; 74(4):314-320. PubMed ID: 30771996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Texture analysis- and support vector machine-assisted diffusional kurtosis imaging may allow in vivo gliomas grading and IDH-mutation status prediction: a preliminary study.
    Bisdas S; Shen H; Thust S; Katsaros V; Stranjalis G; Boskos C; Brandner S; Zhang J
    Sci Rep; 2018 Apr; 8(1):6108. PubMed ID: 29666413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma grading, molecular feature classification, and microstructural characterization using MR diffusional variance decomposition (DIVIDE) imaging.
    Li S; Zheng Y; Sun W; Lasič S; Szczepankiewicz F; Wei Q; Han S; Zhang S; Zhong X; Wang L; Li H; Cai Y; Xu D; Li Z; He Q; van Westen D; Bryskhe K; Topgaard D; Xu H
    Eur Radiol; 2021 Nov; 31(11):8197-8207. PubMed ID: 33914116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A correlation between diffusion kurtosis imaging and the proliferative activity of brain glioma.
    Tonoyan AS; Pronin IN; Pitshelauri DI; Shishkina LV; Fadeeva LM; Pogosbekyan EL; Zakharova NE; Shults EI; Khachanova NV; Kornienko VN; Potapov AA
    Zh Vopr Neirokhir Im N N Burdenko; 2015; 79(6):5-14. PubMed ID: 26977789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amide proton transfer imaging might predict survival and IDH mutation status in high-grade glioma.
    Joo B; Han K; Ahn SS; Choi YS; Chang JH; Kang SG; Kim SH; Zhou J; Lee SK
    Eur Radiol; 2019 Dec; 29(12):6643-6652. PubMed ID: 31175415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T.
    Paech D; Windschuh J; Oberhollenzer J; Dreher C; Sahm F; Meissner JE; Goerke S; Schuenke P; Zaiss M; Regnery S; Bickelhaupt S; Bäumer P; Bendszus M; Wick W; Unterberg A; Bachert P; Ladd ME; Schlemmer HP; Radbruch A
    Neuro Oncol; 2018 Nov; 20(12):1661-1671. PubMed ID: 29733378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo assessment of tumor heterogeneity in WHO 2016 glioma grades using diffusion kurtosis imaging: Diagnostic performance and improvement of feasibility in routine clinical practice.
    Hempel JM; Schittenhelm J; Bisdas S; Brendle C; Bender B; Bier G; Skardelly M; Tabatabai G; Castaneda Vega S; Ernemann U; Klose U
    J Neuroradiol; 2018 Feb; 45(1):32-40. PubMed ID: 28865921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
    Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
    Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined texture analysis of dynamic contrast-enhanced MRI with histogram analysis of diffusion kurtosis imaging for predicting IDH mutational status in gliomas.
    Pan T; Su CQ; Tang WT; Lin J; Lu SS; Hong XN
    Acta Radiol; 2023 Sep; 64(9):2552-2560. PubMed ID: 37331987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of MR diffusion kurtosis and neurite orientation dispersion and density imaging in evaluating gliomas.
    Genç B; Aslan K; Özçağlayan A; İncesu L
    J Neuroimaging; 2023; 33(4):644-651. PubMed ID: 37170070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combined application of amide proton transfer imaging and diffusion kurtosis imaging for differentiating stage Ia endometrial carcinoma and endometrial polyps.
    Tian S; Chen A; Li Y; Wang N; Ma C; Lin L; Wang J; Liu A
    Magn Reson Imaging; 2023 Jun; 99():67-72. PubMed ID: 36603780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.